Related Experiment Video

Updated: Jun 9, 2026

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

Aggregate cardiovascular risk is a stronger statistical correlate of clinically evident diabetic peripheral

Mayowa O Owolabi1, Arinola Ipadeola, Jokotade O Adeleye

  • 1Department of Medicine, University College Hospital, Ibadan, Nigeria. mayowaowolabi@yahoo.com

Journal of the National Medical Association
|September 2, 2010
PubMed

Insights

Cardiovascular risk load, not just HbA1c, significantly predicts diabetic peripheral neuropathy. Managing multiple risk factors is crucial for preventing nerve damage in diabetes patients.

Area of Science:

  • Endocrinology and Metabolism
  • Neurology
  • Cardiovascular Medicine

Background:

  • Diabetic peripheral neuropathy (DPN) development is influenced by chronic hyperglycemia (HbA1c) and other vascular risk factors.
  • The comparative impact of aggregate cardiovascular risk load versus HbA1c on DPN risk remains understudied.

Purpose of the Study:

  • To compare the predictive power of aggregate cardiovascular risk load against HbA1c for clinically evident DPN.

Main Methods:

  • A cohort of 277 type 2 diabetes outpatients in Nigeria were assessed.
  • Neuropathy was diagnosed using the Michigan Neuropathy Screening Instrument (MNSI) criteria.
  • HbA1c and aggregate cardiovascular risk load (UKPDS risk engines) were determined for all participants.

Main Results:

  • 71.1% of patients exhibited clinically evident DPN.
  • HbA1c showed no significant correlation with DPN development (p = .465).
  • Aggregate cardiovascular risk load demonstrated a strong correlation with DPN (p = .002) and was a superior predictor in regression analysis.

Conclusions:

  • Aggregate cardiovascular risk load is a more potent correlate and predictor of DPN than HbA1c.
  • These findings suggest that comprehensive cardiovascular risk management is vital for DPN prevention and monitoring.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
Diabetic Neuropathy01:22

Diabetic Neuropathy

DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...